# A Phase 1 QT Study in Healthy Male Subjects

> **NCT01986894** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 72 (actual)

## Conditions studied

- Clinical Pharmacology, Healthy Volunteer Study

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pomalidomide
- **DRUG:** Pomalidomide
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01986894
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-18
- **Primary completion:** 2013-12-02
- **Final completion:** 2013-12-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986894, "A Phase 1 QT Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01986894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*